ZOHRA DAMAWAND: Open Payments
NPI 1043799703 · MURRIETA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$237 in 11 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $15 · 2025 $237
Food & beverage: $237
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 2 | $47 |
| Sumitomo Pharma America, Inc. | 2 | $31 |
| ABBVIE INC. | 1 | $31 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $27 |
| AstraZeneca Pharmaceuticals LP | 1 | $26 |
| Novo Nordisk Inc | 1 | $21 |
| Exact Sciences Corporation | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
Products named: GEMTESA, UBRELVY, Kerendia, LOKELMA, KISUNLA, MOUNJARO, Rybelsus, Cologuard Collection Kit.
Industry payments across CA — which companies pay providers there.
